iCrowd Newswire
08 Oct 2019, 17:33 GMT+10
San Francisco, October 8, 2019: Latest study by Grand View Research, Inc. titled "Electrophysiology Devices Market Size, Share & Trends Analysis By Application (Treatment, Diagnostic), By Indication (AF, SVT, AVNRT, WPW), By End Use, By Region, And Segment Forecasts, 2019 - 2026", reveals that the global electrophysiology devices market size is expected to reach USD 12.2 billion by 2026, according to a new report by Grand View Research, Inc. expanding at a CAGR of 11.70% over the forecast period. The demand for electrophysiology devices is expected to increase owing to growing old age population and frequent cardiac arrhythmias incidents. Adoption of ablation and diagnostics techniques among physicians has resulted in increased usage of the product in the past few years and is likely to drive market growth. Development of new devices such as Nanostim-dual-chamber leadless pacemaker is also anticipated to fuel demand in the market.
Some key findings from the report:
- Electrophysiology diagnostic devices held a major share in the application segment in 2018. Collectively, cardiac monitors held the largest market share in electrophysiology diagnostic segment. The devices include Holter monitors, ECG monitors, and Insertable Cardiac Monitors (ICM). Growth can be attributed to increasing usage of digital and portable systems in the ambulatory setting and improving diagnostic interventional capabilities of healthcare consultants.
- EP mapping and imaging systems are anticipated to grow rapidly during the forecast period. Technological improvements such as Optima IGS 320 and GE Healthcare's Innova IGS 520 are projected to provide future opportunities for growth. These are dose efficient products and cardiac imaging systems that allow interventional cardiologist to perform compound interventional procedures with accuracy and ease.
- Electrophysiology treatment devices include pacemakers, implantable cardioverter defibrillators (ICD) and catheters. Pacemakers emerged as the largest treatment devices segment in 2018 owing to rising prevalence of different types of arrhythmia among the population and extensive usage of cardiac rhythm management devices. However, rising costs related to the product, existence of strict regulations and accessibility of substitute therapies are anticipated to hamper the growth. Automated external defibrillators (AEDs) are expected to witness high growth rate during the forecast period attributed to increasing use in treating out-of-hospital cases of cardiac arrest.
- North America held the largest market share in 2018 owing to a high patient base of cardiac arrhythmia resulting from unhealthy lifestyle habits. Increasing demand for the latest healthcare infrastructure and rising consumer awareness are anticipated to propel growth.
- Asia-Pacific is a lucrative market owing to the high rate of unmet medical requirements leading to an increase in the number of patients. Rapid developments in healthcare infrastructure and increase in disposable income in emerging economies such as India and China are expected to provide new avenues and opportunities for companies to capitalize over the forecast period.
- There are top 4 players who command around 60% of the electrophysiology devices market. Boston Scientific Corporation, Medtronic Plc., Abbot Laboratories, and Biosense Webster, Inc., is predominantly led by powerful product portfolios and significant brand recognition. Other players include Biotronik SE & Co. KG.
The final report on global electrophysiology devices market has been segmented on the basis of medical condition, service and region:
Electrophysiology Devices Application Outlook (Revenue, USD Million; 2015 - 2026)
Treatment Devices
Implantable Cardioverter Defibrillators (ICDs)
Automated external defibrillators (AEDs)
Pacemakers
CRT-P
CRT-D
Catheters
Others
Diagnostic Devices
Holter Monitoring Devices
Diagnostic Electrophysiology Catheters
Electrocardiograph (ECG)
EP Mapping & Imaging Systems
Implantable cardiac monitors (ICM)
Others
Electrophysiology Devices Indication Outlook (Revenue, USD Million; 2015 - 2026)
Atrial Fibrillation (AF)
Supraventricular Tachycardia
Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
Wolff-Parkinson-White Syndrome (WPW)
Bradycardia
Others
Electrophysiology Devices End-Use Outlook (Revenue, USD Million; 2015 - 2026)
Hospitals
Ambulatory Surgical Centers
Others
Electrophysiology Devices Region Outlook (Revenue, USD Million; 2015 - 2026)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
Latin America
Brazil
Mexico
Middle East and Africa
Saudi Arabia
South Africa
Cardiac ablation has gained popularity as the first-line treatment, rendering a 95% success rate for several rhythm disorders and is anticipated to be a key driving factor for growth. Diagnostic electrophysiology catheters are estimated to grow at high CAGR in the foreseeable future. Technological developments such as laser ablation, cryo-ablation, and ultrasound ablation, coupled with optimized mapping techniques are anticipated to augment market growth over the forecast period.
Browse more market research report from Medical Devices Category
For your custom research requirements please visit Grand View Research
Contact Information:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Get a daily dose of Business Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Business Sun.
More InformationWASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
NEW YORK CITY, New York: Financial markets kicked off the week on a cautious note as President Donald Trump rolled out a fresh round...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
CULVER CITY, California: TikTok is preparing to roll out a separate version of its app for U.S. users, as efforts to secure a sale...
WASHINGTON, D.C.: The U.S. government has granted GE Aerospace permission to resume jet engine shipments to China's COMAC, a person...
Nearly 2,000 jobs in the executive branch dealing with foreign policy are reportedly on the chopping block The US State Department...
New Delhi [India], July 11 (ANI): The recall of Chinese employees from the Foxconn India factory, which manufactures Apple iPhones,...